Results

Oyster Point Pharma Inc.

10/18/2021 | Press release | Distributed by Public on 10/18/2021 04:20

Oyster Point Pharma Announces FDA Approval of TYRVAYA™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease - Form 8-K